Balyasny Asset Management’s Kazia Therapeutics KZIA Stock Holding History

Balyasny Asset Management’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.44M	Buy	+193,114	New	+$1.34M	﹤0.01%	1931

Other funds holding KZIA

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Balyasny Asset Management's KZIA Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Kazia Therapeutics (KZIA) in Q1 2026: 193,114 shares worth $1.44M. The stake represents ﹤0.01% of the portfolio and ranks #1931 among its holdings.

23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

Balyasny Asset Management held 193,114 shares of Kazia Therapeutics worth $1.44M as of Q1 2026.
Kazia Therapeutics was a new Balyasny Asset Management position in Q1 2026.
Kazia Therapeutics made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1931 holding.
23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.